{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:08:50Z","timestamp":1791407330085,"version":"4.3.3"},"reference-count":35,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1984,7,1]]},"DOI":"10.1136\/hrt.52.1.106","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"106-111","source":"Crossref","is-referenced-by-count":37,"title":["Detrimental effects of verapamil in patients with primary pulmonary hypertension."],"prefix":"10.1136","volume":"52","author":[{"given":"M","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Yushak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"195","article-title":"Recent studies in primary pulmonary hypertension including pharmacodynamic observations on pulmonary vascular resistance","volume":"30","author":"Dresdale, D.T.; Michtom, R.J.; Schultz, M.","year":"1954","unstructured":"Dresdale DT, Michtom RJ, Schultz M. Recent studies in primary pulmonary hypertension including pharmacodynamic observations on pulmonary vascular resistance. Bull NY Acad Med 1954; 30: 195-207.","journal-title":"Bull NY Acad Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/01.CIR.42.6.1163","article-title":"Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases","volume":"42","author":"Wagenvoort, C.A.; Wagenvoort, N.","year":"1970","unstructured":"Wagenvoort CA, Wagenvoort N. Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases. Calculation 1970; 42: 1163-84.","journal-title":"Calculation"},{"key":"ref_3","first-page":"50","article-title":"Microarteriographic studies of primary pulmonary hypertension","volume":"95","author":"Reeves, J.T.; Noonan, J.A.","year":"1973","unstructured":"Reeves JT, Noonan JA. Microarteriographic studies of primary pulmonary hypertension. Arch Pathol 1973; 95: 50-5.","journal-title":"Arch Pathol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-8703(83)90288-0","article-title":"Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response","volume":"105","author":"Rich, S.; Martinez, J.; Lam, W.; Levy, P.S.; Rosen, K.M.","year":"1983","unstructured":"Rich S, Martinez J, Lam W, Levy PS, Rosen KM. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Am HeartJ 1983; 105: 119-27.","journal-title":"Am HeartJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM197612162952506","article-title":"Primary pulmonary hypertension: favorable effect of isoproterenol","volume":"295","author":"Shettigar, U.R.; Hultgren, H.N.; Specter, M.; Martin, R.; Davies, D.H.","year":"1976","unstructured":"Shettigar UR, Hultgren HN, Specter M, Martin R, Davies DH. Primary pulmonary hypertension: favorable effect of isoproterenol. N EnglJ Med 1976; 295: 1414-5.","journal-title":"N EnglJ Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM198001103020204","article-title":"Diazoxide in primary pulmonary hypertension","volume":"302","author":"Khinke, W.P.; Gilbert, J.A.L.","year":"1980","unstructured":"Khinke WP, Gilbert JAL. Diazoxide in primary pulmonary hypertension. N Engl J Med 1980; 302: 91-2.","journal-title":"N Engl J Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198001103020201","article-title":"Oral hydralazine therapy for primary pulmonary hypertension","volume":"302","author":"Rubin, L.J.; Peter, R.H.","year":"1980","unstructured":"Rubin LJ, Peter RH. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med 1980; 302: 69-73.","journal-title":"N Engl J Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJM198206033062203","article-title":"Deleterious effects of hydralazine in patients with pulmonary hypertension","volume":"306","author":"Packer, M.; Greenberg, B.; Massie, B.; Dash, H.","year":"1982","unstructured":"Packer M, Greenberg B, Massie B, Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl I Med 1982; 306: 1326-31.","journal-title":"N Engl I Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/hrt.42.3.362","article-title":"Diazoxide in treatment of primary pulmonary hypertension","volume":"42","author":"Rubino, J.M.; Schroeder, J.S.","year":"1979","unstructured":"Rubino JM, Schroeder JS. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J 1979; 42: 362-3.","journal-title":"Br Heart J"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pa.17.040177.001053","article-title":"Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle","volume":"17","author":"Fleckenstein, A.","year":"1977","unstructured":"Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol 1977; 17: 149-66.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0002-9149(80)90366-5","article-title":"Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem","volume":"46","author":"Henry, P.D.","year":"1980","unstructured":"Henry PD. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol 1980; 46: 1047-58.","journal-title":"Am J Cardiol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198006053022301","article-title":"Nifedipine therapy for coronary artery spasm","volume":"302","author":"Antman, E.; Muller, J.; Goldberg, S.","year":"1980","unstructured":"Antman E, Muller J, Goldberg S, et al. Nifedipine therapy for coronary artery spasm. N Engl 7 Med 1980; 302: 1269-73.","journal-title":"N Engl 7 Med"},{"key":"ref_13","first-page":"862","article-title":"A controlled trial of verapamil for Prinzmetal's variant angna. NEngl j Med","volume":"304","author":"Johnson, S.M.; Mauritson, D.R.; Willerson, J.T.; Hillis, L.D.","year":"1981","unstructured":"Johnson SM, Mauritson DR, Willerson JT, Hillis LD. A controlled trial of verapamil for Prinzmetal's variant angna. NEngl j Med 1981; 304: 862-6."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM198303173081103","article-title":"Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage","volume":"308","author":"Allen, G.S.; Ahn, H.S.; Preziosi, T.J.","year":"1983","unstructured":"Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308: 619-24.","journal-title":"N Engl J Med"},{"key":"ref_15","first-page":"8803","article-title":"Controlled double blind trial of nifedipine in the treatment of Raynaud's phenomenon","volume":"308","author":"Rodeheffer, R.J.; Rommer, J.A.; Wigley, F.; Smith, C.R.","year":"1983","unstructured":"Rodeheffer RJ, Rommer JA, Wigley F, Smith CR. Controlled double blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983; 308: 8803.","journal-title":"N Engl J Med"},{"key":"ref_16","series-title":"Circulation 1981; 64 (suppl IV): IV-150","article-title":"Verapamil: a mild epicardial coronary dilator, inhibits sympathetic and erogonovine-induced coronary constriction in humans","author":"Brown, B.G.; Pierce, C.D.; Petersen, R.B.; Singh, B.N.; Bolson, E.L.; Dodge, H.T.","unstructured":"Brown BG, Pierce CD, Petersen RB, Singh BN, Bolson EL, Dodge HT. Verapamil: a mild epicardial coronary dilator, inhibits sympathetic and erogonovine-induced coronary constriction in humans [Abstract]. Circulation 1981; 64 (suppl IV): IV-150."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9149(83)80035-6","article-title":"Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension","volume":"51","author":"Young, T.E.; Lundquist, L.J.; Chesler, E.; Weir, E.K.","year":"1983","unstructured":"Young TE, Lundquist LJ, Chesler E, Weir EK. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension. Am J Cardiol 1983; 51: 195-200.","journal-title":"Am J Cardiol"},{"key":"ref_18","series-title":"Fed Proc 1981","first-page":"590","article-title":"Vasodilator actions of nifedipine and verapamil in the pulmonary vascular bed","volume":"40","author":"Lippton, H.L.; Nandiwada, P.A.; Kadowitz, P.J.; Hyman, A.L.","unstructured":"Lippton HL, Nandiwada PA, Kadowitz PJ, Hyman AL. Vasodilator actions of nifedipine and verapamil in the pulmonary vascular bed [Abstract]. Fed Proc 1981; 40: 590."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198106253042606","article-title":"Inhibition of hypoxic pulmonary vasoconstriction by nifedipine","volume":"304","author":"Simonneau, G.; Escourrou, P.; Duroux, P.; Lockhart, A.","year":"1981","unstructured":"Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Englj Med 1981; 304: 1582-5.","journal-title":"N Englj Med"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.44.3.352","article-title":"Primary pulmonary hypertension: effects of nifedipine","volume":"44","author":"Camerini, F.; Alberti, E.; Klugmann, S.; Salvi, A.","year":"1980","unstructured":"Camerini F, Alberti E, Klugmann S, Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J 1980; 44: 352-6.","journal-title":"Br Heart J"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0002-8703(83)90414-3","article-title":"Primary pulmonary hypertension improved by long-term oral administration of nifedipine","volume":"105","author":"Saito, D.; Haraoka, S.; Yoshida, H.","year":"1983","unstructured":"Saito D, Haraoka S, Yoshida H, et al. Primary pulmonary hypertension improved by long-term oral administration of nifedipine. Am Heart J 1983; 105: 1041-2.","journal-title":"Am Heart J"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-8703(83)90500-8","article-title":"Nifedipine in the treatment of primary pulmonary hypertension","volume":"105","author":"Jr, Wise JR","year":"1983","unstructured":"Wise JR Jr. Nifedipine in the treatment of primary pulmonary hypertension. Am Heart J 1983; 105: 693-4.","journal-title":"Am Heart J"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-8703(83)90539-2","article-title":"Sustained beneficial effect of nifedipine in primary pulmonary hypertension","volume":"105","author":"PJ, De Feyter; HJJ, Kerkkamp; de Jong JP","year":"1983","unstructured":"De Feyter PJ, Kerkkamp HJJ, de Jong JP. Sustained beneficial effect of nifedipine in primary pulmonary hypertension. Am HeartJ 1983; 105: 333-4.","journal-title":"Am HeartJ"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-99-4-433","article-title":"Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation","volume":"99","author":"Rubin, L.J.; Nicod, P.; Hillis, L.D.; Firth, B.G.","year":"1983","unstructured":"Rubin LJ, Nicod P, Hillis LD, Firth BG. Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation. Ann Intern Med 1983; 99: 433-8.","journal-title":"Ann Intern Med"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.RES.38.2.99","article-title":"Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs","volume":"38","author":"McMurtry, I.F.; Davidson, A.B.; Reeves, J.T.; Grover, R.F.","year":"1976","unstructured":"McMurtry IF, Davidson AB, Reeves JT, Grover RF. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res 1976; 38: 99-104.","journal-title":"Circ Res"},{"key":"ref_26","first-page":"6114","article-title":"Attentuation of hypoxic pulmonary vasoconstriction by verapamil","volume-title":"intact dogs. Proc Soc Exp Biol Med","volume":"151","author":"Tucker, A.; McMurtry, I.F.; Grover, R.F.; Reeves, J.T.","year":"1976","unstructured":"Tucker A, McMurtry IF, Grover RF, Reeves JT. Attentuation of hypoxic pulmonary vasoconstriction by verapamil in intact dogs. Proc Soc Exp Biol Med 1976; 151: 6114."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.0954-6820.1978.tb08443.x","article-title":"Verapamil and pulmonary hypertension","volume":"204","year":"1978","unstructured":"Landmark K, Refsum AM, Simonsen S, Storstein 0. Verapamil and pulmonary hypertension. Acta Med Scand 1978; 204: 299-302.","journal-title":"Acta Med Scand"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.CIR.62.4.669","article-title":"Therapeutic implications of slow-channel blockade in cardiocirculatory disorders","volume":"62","author":"Ellrodt, G.; Chew, C.Y.C.; Singh, B.N.","year":"1980","unstructured":"Ellrodt G, Chew CYC, Singh BN. Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. Circulation 1980; 62: 669-79.","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0002-8703(63)90011-5","article-title":"The hemodynamic effects of isoproterenol on pulmonary hypertension in man","volume":"65","author":"TD, Jr, Lee; GC, Roveti; RS, Ross","year":"1963","unstructured":"Lee TD Jr, Roveti GC, Ross RS. The hemodynamic effects of isoproterenol on pulmonary hypertension in man. Am Heart 1963; 65: 361-7.","journal-title":"Am Heart"},{"key":"ref_30","first-page":"1177","article-title":"Unfavorable hemodynamic and clinical effects of isoproterenol in primary pulmonary hypertension","volume":"3","author":"Elkayam, U.; Frishman, W.H.; Yoran, C.; Strom, J.; Sonnenblick, E.H.; Cohen, M.N.","year":"1978","unstructured":"Elkayam U, Frishman WH, Yoran C, Strom J, Sonnenblick EH, Cohen MN. Unfavorable hemodynamic and clinical effects of isoproterenol in primary pulmonary hypertension. Cardiovasc Med 1978; 3: 1177-80.","journal-title":"Cardiovasc Med"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0002-8703(82)90256-3","article-title":"Nifedipine therapy in angina pectoris: evaluation of safety and side effects","volume":"104","author":"Terry, R.W.","year":"1982","unstructured":"Terry RW. Nifedipine therapy in angina pectoris: evaluation of safety and side effects. Am Heart J 1982; 104: 681-9.","journal-title":"Am Heart J"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0002-8703(78)90515-X","article-title":"Pulmonary vascular effects of verapamil","volume":"95","author":"Davidson, A.; McMurtry, I.; Reeves, J.T.","year":"1978","unstructured":"Davidson A, McMurtry I, Reeves JT. Pulmonary vascular effects of verapamil. Am Heart J 1978; 95: 810-1.","journal-title":"Am Heart J"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000194026","article-title":"Effects of verapamil and aspirn on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats","volume":"37","author":"Kentera, D.; Susic, D.; Zdravkovic, M.","year":"1979","unstructured":"Kentera D, Susic D, Zdravkovic M. Effects of verapamil and aspirn on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats. Respiration 1979; 37: 192-6.","journal-title":"Respiration"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01734125","article-title":"Einfluss von Beta-Receptorenblockern und verwandten Substanzen auf Erregung, Kontraktion und Energiestoffwechsel der Myokardfaser","volume":"46","author":"Fleckenstein, A.; Doring, H.J.; Kammermeier, H.","year":"1968","unstructured":"Fleckenstein A, Doring HJ, Kammermeier H. Einfluss von Beta-Receptorenblockern und verwandten Substanzen auf Erregung, Kontraktion und Energiestoffwechsel der Myokardfaser. Klin Wochenschr 1968; 46: 343-51.","journal-title":"Klin Wochenschr"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0002-9149(81)90194-6","article-title":"Influence of the severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease","volume":"47","author":"Chew, C.Y.C.; Hecht, H.S.; Collett, J.T.; McAllister, R.G.; Singh, B.N.","year":"1981","unstructured":"Chew CYC, Hecht HS, Collett JT, McAllister RG, Singh BN. Influence of the severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J7 Cardiol 1981; 47: 917-22.","journal-title":"Am J7 Cardiol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.52.1.106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T02:44:40Z","timestamp":1737427480000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.52.1.106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,7,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984,7,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.52.1.106","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1984,7,1]]}}}